# Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)

> **NCT00063622** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 247 (actual)

## Conditions studied

- Liver Diseases

## Interventions

- **DRUG:** Pioglitazone
- **DIETARY_SUPPLEMENT:** Vitamin E
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT00063622
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-09
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00063622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00063622, "Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00063622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*